Shares of Kailera Therapeutics fell 10% on Tuesday, a decline triggered by late-stage trial results showing that its oral ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

This report presents the long-term follow-up results of JCOG1008, phase 2/3 trial comparing weekly cisplatin versus 3-weekly cisplatin for patients with postoperative high-risk locally advanced ...

The BrioVAD pump is the first implantable device from China to receive approval for clinical trials in America A "Chinese ...

At the American Society of Clinical Oncology (ASCO) meeting, results from the OPTIMA trial suggested that genomic testing may help identify additional patients with hormone ...

In Phase 3 trial in obesity/overweight in China, HRS-7535 achieved a mean weight loss of up to 10.9% at Week 44 and a mean weight loss of up to ...

Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.

Kailera Therapeutics Inc. KLRA stock fell about 9% on Tuesday after the company reported positive topline results from two ...

In a randomized clinical trial involving patients with urinary retention, reusable catheters were found to be noninferior to ...

Treating pain while in the field can be very demanding. Researchers have finally identified an effective alternative for ...

Get all the latest news and updates on Serum Institute only on News18.com. Read Politics news, current affairs and news headlines online on Serum Institute News today.